tiprankstipranks
Advertisement
Advertisement

BMRN Stock Latest News

Ascendis Pharma ‘oversold’ following ITC development, says Oppenheimer
The FlyAscendis Pharma ‘oversold’ following ITC development, says Oppenheimer
7d ago
ASND
BMRN
BioMarin Shareholders Approve 2026 Governance and Equity Plan
PremiumCompany Announcements
BioMarin Shareholders Approve 2026 Governance and Equity Plan
11d ago
8K
BMRN
Jason Gerberry Maintains Buy on BioMarin, Reiterates $80 Price Target Despite Voxzogo Patent Uncertainty
PremiumRatings
Jason Gerberry Maintains Buy on BioMarin, Reiterates $80 Price Target Despite Voxzogo Patent Uncertainty
15d ago
BMRN
3 Best Stocks to Buy This Week, According to Analysts – May 25-May 29
PremiumMarket News
3 Best Stocks to Buy This Week, According to Analysts – May 25-May 29
21d ago
BMRN
FUTU
BioMarin price target lowered to $111 from $116 at Canaccord
PremiumThe Fly
BioMarin price target lowered to $111 from $116 at Canaccord
25d ago
BMRN
Buy Rating Reaffirmed on BioMarin as Voxzogo Skeletal Disorder Opportunity Expands; $94 Price Target Maintained
PremiumRatingsBuy Rating Reaffirmed on BioMarin as Voxzogo Skeletal Disorder Opportunity Expands; $94 Price Target Maintained
26d ago
BMRN
BioMarin’s Voxzogo meets endpoint in Phase 3 pediatric hypochondroplasia trial
Premium
The Fly
BioMarin’s Voxzogo meets endpoint in Phase 3 pediatric hypochondroplasia trial
26d ago
BMRN
StubHub, Jazz Pharmaceuticals upgraded: Wall Street’s top analyst calls
Premium
The Fly
StubHub, Jazz Pharmaceuticals upgraded: Wall Street’s top analyst calls
27d ago
AMT
BAP
BioMarin price target lowered to $80 from $85 at BofA
PremiumThe Fly
BioMarin price target lowered to $80 from $85 at BofA
28d ago
BMRN
BioMarin initiated with a Buy at Citi
PremiumThe Fly
BioMarin initiated with a Buy at Citi
28d ago
BMRN
BioMarin price target lowered to $62 from $64 at Leerink
PremiumThe Fly
BioMarin price target lowered to $62 from $64 at Leerink
28d ago
BMRN
BioMarin price target lowered to $50 from $55 at H.C. Wainwright
PremiumThe Fly
BioMarin price target lowered to $50 from $55 at H.C. Wainwright
28d ago
BMRN
BioMarin’s BMN 401 meets 1 of 2 endpoints in Phase 3 ENPP1 trial
PremiumThe FlyBioMarin’s BMN 401 meets 1 of 2 endpoints in Phase 3 ENPP1 trial
28d ago
BMRN
Morgan Stanley Sees the S&P 500 Hitting 8,300 – 2 Stocks It Says Could Surge Alongside It
Premium
Market News
Morgan Stanley Sees the S&P 500 Hitting 8,300 – 2 Stocks It Says Could Surge Alongside It
1M ago
ARXS
BMRN
BioMarin Extends BMN 351 Duchenne Study, Keeping Long-Term Data in Focus for Investors
Premium
Company Announcements
BioMarin Extends BMN 351 Duchenne Study, Keeping Long-Term Data in Focus for Investors
1M ago
BMRN
Dell downgraded, Uber upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Dell downgraded, Uber upgraded: Wall Street’s top analyst calls
1M ago
CG
FTV
BioMarin reinstated with a Neutral at Goldman Sachs
PremiumThe Fly
BioMarin reinstated with a Neutral at Goldman Sachs
1M ago
BMRN
BioMarin price target raised to $116 from $104 at Canaccord
PremiumThe Fly
BioMarin price target raised to $116 from $104 at Canaccord
1M ago
BMRN
BioMarin price target lowered to $119 from $120 at Morgan Stanley
PremiumThe Fly
BioMarin price target lowered to $119 from $120 at Morgan Stanley
1M ago
BMRN
BioMarin price target raised to $120 from $110 at Evercore ISI
PremiumThe FlyBioMarin price target raised to $120 from $110 at Evercore ISI
1M ago
BMRN
BioMarin price target lowered to $82 from $94 at Bernstein
Premium
The Fly
BioMarin price target lowered to $82 from $94 at Bernstein
1M ago
BMRN
BioMarin: Buy Rating Reiterated on Amicus Acquisition Upside and Pipeline Catalysts; $85 Price Target Unchanged
Premium
Ratings
BioMarin: Buy Rating Reiterated on Amicus Acquisition Upside and Pipeline Catalysts; $85 Price Target Unchanged
1M ago
BMRN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >